Neuromuscular Blocking Agents: an Argument for Their Adequate Use

  • Roberto Carlo Rivera Díaz Anestesiólogo. Docente de Anestesia y Dolor, Universidad CES, Instituto Colombiano del Dolor. Medellín, Colombia.
  • Johan Sebastián Rivera Díaz Residente de Anestesia, Universidad CES, Medellín, Colombia.
Keywords: Neuromuscular blocking agents, intubation, medical emergencies, risk.

Abstract

Introduction. The debate regarding the use of muscle relaxants is still ongoing, with arguments against such as their adverse effects and published risks, and arguments in favor such as the need to ensure rapid and adequate intubation in emergency cases, the benefit of an easy surgical field for the surgeon, and other reported benefits.

Objective. To review aspects associated with the adequate use of neuromuscular blocking agents in anesthesia.

Materials and methods. Narrative review of the scientific literature available on the subject that focused on indications, risks, benefits and monitoring.

Results. The absolute indication of muscle relaxants is rapid-sequence intubation, but there are other situations where they are recommended: Intubation in elective surgery, certain types of special surgical procedures and situations (ARDS, electroconvulsive therapy, intra-abdominal hypertension, intracranial hypertension), and they may be avoided in many general anesthesia cases. Most important is to be aware of their indications, risks and adequate use.

Conclusion. In conclusion, there are situations where the use of muscle relaxants may be avoided, but there are also instances were they are a requirement and it is in those cases where they are recommended. Therefore, if they are to be used, they must be the ideal choice for the individual patient at the right time and the right dose, and always under appropriate monitoring.

References

1. Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery: based on a study of 599, 548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg. 1954;140:2-35.
2. Leuwer M. Do we need muscular blockers in ambulatory anaesthesia? Curr Opin Anaesthesiol. 2000;13:625-9.
3. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg. 2003;97:1381-95. Review.
4. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth. 2007;98:302-16.
5. Moore EW, Hunter JM. The new neuromuscular blocking agents: do they offer any advantages? Br J Anaesth. 2001;87:912-25. Review.
6. González MP, Rivera RC, Ordoñez JE, et al. Evaluación clínica de la calidad de la intubación entodotraqueal con remifentanilo-propofol-sevofluorano comparada con remifentanilo-propofol-rocuronio: ensayo clínico aleatorizado doble ciego. Rev Esp Anestesiol Reanim. 2010;57:351-6.
7. Stevens JB, Wheatley L. Tracheal intubation in ambulatory surgery patients: using remifentanil and propofol without muscle relaxants. Anesth Analg. 1998;86:45-9.
8. Woods AW, Allam S. Tracheal intubation without the use of neuromuscular blocking agents. Br J Anaesth. 2005;94:150-8. Epub 2004 Oct 29. Review.
9. El-Orbany M, Connolly LA. Rapid sequence induction and intubation: current controversy. Anesth Analg. 2010;110:1318-25. Epub 2010 Mar 17. Review.
10. Perry JJ, Lee JS, Sillberg VA, et al. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev. 2008;16:CD002788. Review.
11. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111:120-8. Epub 2010 May 4. Review.
12. Murphy GS, Szokol JW, Franklin M, et al. Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium. Anesth Analg. 2004;98:193-200.
13. Bissinger U, Schimek F, Lenz G. Postoperative residual parálisis and respiratory status: a comparative study of pancuroniumand vecuronium. Physiol Res. 2000;49:455-62.
14. Slutsky AS. Neuromuscular blocking agents in ARDS. N Engl J Med. 2010; 363:1176-80.
15. Bwalya GM, Srinivasan V, Wang M. Electroconvulsive therapy anesthesia practice patterns: results of a UK postal survey. J ECT. 2011;27:81-5.
16. Miller RD. Miller's Anesthesia 6th ed. Philadelphia, PA: Elsevier Churchill Livingstone, 2005. p. 481-572
17. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg. 2010;111:129-40.
How to Cite
1.
Rivera Díaz RC, Rivera Díaz JS. Neuromuscular Blocking Agents: an Argument for Their Adequate Use. Colomb. J. Anesthesiol. [Internet]. 2011 Jul. 1 [cited 2024 Apr. 29];39(3):352-7. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/841

Downloads

Download data is not yet available.
Published
2011-07-01
How to Cite
1.
Rivera Díaz RC, Rivera Díaz JS. Neuromuscular Blocking Agents: an Argument for Their Adequate Use. Colomb. J. Anesthesiol. [Internet]. 2011 Jul. 1 [cited 2024 Apr. 29];39(3):352-7. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/841
Section
Essay

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code